Pharmacologic inhibition of both the immune-checkpoint molecule PD-L1 and vascular endothelial growth factor improves survival among persons with hepatocellular carcinoma. The success of this combi ...

Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is characterized by a high rate of metastasis ...

Professor Jang Soo-jin of the Department of Nuclear Medicine at Cha Medical University (Director Yoon Sang-wook) and ...

Hepatocellular carcinoma is a cancer that starts in your liver. It's different from "secondary" liver cancers, which have spread to the liver from other organs. If caught early, it can sometimes ...

The FDA approved Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma, according to a press ...

In the early stages of hepatocellular carcinoma (HCC), doctors may recommend surgical removal, a liver transplant, or ablation. Learn more about treating HCC here.

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths ...

In a new study published in the journal Chemical Science, researchers at the University of Toronto along with Insilico Medicine developed a potential treatment for hepatocellular carcinoma (HCC ...

The selective internal radiation therapy SIR-Spheres has been approved by the FDA for use in patients with unresectable ...

Fibrolamellar carcinoma. Fibrolamellar carcinoma is a rare type of HCC. Fibrolamellar carcinoma tends to develop in people in their 20s or 30s. It’s not usually linked with cirrhosis or infection with ...

Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, accounting for the majority of primary liver cancer cases. It is the fourth leading cause of cancer-related deaths worldwide.

Hepatocellular Carcinoma (HCC) is the most common type of liver cancer. Learn about symptoms, causes, risk factors, treatment, and more.